Drugs / elbasvir-grazoprevir
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03093415 | May 2017 → Jun 2019 | hepatitis C virus infection, substance abuse | Oregon Health and Science University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | elbasvir-grazoprevir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03093415 ↗ |